Easy BIO
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Easy BIO makes specialist feed for piglets, the nutritionally sensitive young pigs that require carefully formulated diets distinct from standard livestock feed, and supplies feed additives designed to support gut health and nutrient absorption in farm animals.
Its customers are pig farmers and livestock operations across Korea, where it is listed on KOSDAQ, the country's tech and small-cap exchange. The business operates across two segments: compound piglet feed and feed additives, with the additives segment described in its filing as the highest value-added part of the supply chain.
Summary is AI-generated and may contain errors · figures from DART filings
Easy BIO in five facts
What does Easy BIO do?
Easy BIO makes specialist feed for piglets, the nutritionally sensitive young pigs that require carefully formulated diets distinct from standard livestock feed, and supplies feed additives designed to support gut health and nutrient absorption in farm animals.
Where is Easy BIO listed and in which sector?
Easy BIO (Korean name: 이지바이오) trades under KRX code 353810 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Consumer Staples sector, Food & Beverage.
How large is Easy BIO?
Its market capitalisation was US$139.6M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Easy BIO's latest annual revenue and operating profit?
For fiscal year 2025, Easy BIO reported revenue of US$360M, operating profit of US$34M and net income of US$22.1M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was up 24.1% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Report on large shareholdings (5% rule) (abbreviated)Oct 19
- Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Easy BIO reported consolidated results for FY2025: revenue of US$318M (+24.1% year on year), operating profit of US$30M (+38.8% year on year) and net income of US$19.5M (+47% year on year).
Earnings · Mar 16 - Cash/in-kind dividend decision
Easy BIO declared a cash dividend of US$0.17 per share.
Dividend · Feb 20